Eradication therapy in helicobacter pylori-negative, gastric low-grade mucosa-associated lymphoid tissue lymphoma patients: A systematic review

Journal of Clinical Gastroenterology

Volumn 47, Issue 10, 2013, Pages 824-827

  Zullo, Angelo ^a   Hassan, Cesare ^a   Ridola, Lorenzo ^a   De Francesco, Vincenzo ^c   Rossi, Luigi ^b   Tomao, Silverio ^b   Vaira, Dino ^d   Genta, Robert M ^e,f  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Riuniti Hospital   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e Miraca Research Institute   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

eradication therapy; gastric MALT lymphoma; H. pylori

Indexed keywords

ANTIBIOTIC AGENT;

HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MARGINAL ZONE LYMPHOMA; PRIORITY JOURNAL; REMISSION; REVIEW; STOMACH LYMPHOMA; SYSTEMATIC REVIEW;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LYMPHOMA, B-CELL, MARGINAL ZONE; REMISSION INDUCTION; STOMACH NEOPLASMS; TREATMENT OUTCOME;

EID: 84886596299     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318286ff72     Document Type: Review

References (35)

1. Alakkari A, Zullo A, O'Connor HJ. Helicobacter pylori and nonmalignant diseases. Helicobacter. 2011;16(suppl 1):33-37
2. Stasi R, Provan D. Helicobacter pylori and chronic ITP. Hematology Am Soc Hematol Educ Program. 2008;206-211
3. Qu XH, Huang XL, Xiong P, et al. Does Helicobacter pylori infection play a role in iron deficiency anemia? A metaanalysis. World J Gastroenterol. 2010;16:886-896
4. Fuccio L, Eusebi LH, Bazzoli F. Gastric cancer, Helicobacter pylori infection and other risk factors. World J Gastrointest Oncol. 2010;2:342-347
5. Swerdlow SH, Campo E, Harris NL, et al. The World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: WHO; 2008
6. Zullo A, Hassan C, Cristofari F, et al. Gastric low-grade mucosal-associated lymphoid tissue lymphoma: Helicobacter pylori and beyond. World J Gastrointest Oncol. 2010;2: 181-186
7. Zullo A, Hassan C, Cristofari F, et al. Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol. 2010;8:105-110
8. Zucca E, Dreyling M. ESMO Guidelines Working Group: Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21(suppl 5):v175-v176
9. Ruskoné-Fourmestraux A, Fischbach W, Aleman BMP, et al. EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut. 2011;60:747-758
10. Malfertheiner P, Megraud F, O'Morain CA, et al. European Helicobacter Study Group. Management of Helicobacter pylori infection - the Maastricht IV/Florence Consensus Report. Gut. 2012;61:646-664
11. Zullo A, Hassan C, Andriani A, et al. Treatment of low-grade gastric MALT lymphoma unresponsive to Helicobacter pylori therapy: A pooled-data analysis. Med Oncol. 2010;27:291-295
12. Zullo A, Hassan C, Andriani A, et al. Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: A pooled data analysis. Am J Gastroenterol. 2009;104: 1932-1937
13. Zullo A, Hassan C, Andriani A, et al. Primary low-grade and high-grade gastric MALT lymphoma presentation. J Clin Gastroenterol. 2010;44:340-344
14. Lee SK, Lee YC, Chung JB, et al. Low grade gastric mucosa associated lymphoid tissue lymphoma: Treatment strategies based on 10 year follow-up. World J Gastroenterol. 2004;10:223-226
15. Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med. 1999;131:88-95
16. Ruskoné-Fourmestraux A, Lavergne A, Aegerter PH, et al. Predictive factors for regression of gastric MALT lymphoma after anti-Helicobacter pylori treatment. Gut. 2001;48:297-303
17. Raderer M, Streubel B, Wöhrer S, et al. Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas. Gut. 2006;55:616-618
18. Akamatsu T, Mochizuki T, Okiyama Y, et al. Comparison of localized gastric mucosa-associated lymphoid tissue (MALT) lymphoma with and without Helicobacter pylori infection. Helicobacter. 2006;11:86-95
19. Nozaki K, Nomura S, Shimizu N, et al. Helicobacter pylorinegative/ API2-MALT1 translocation-negative low-grade MALT lymphoma. Gastric Cancer. 2006;9:229-234
20. Dong G, Liu C, Ye H, et al. BCL10 nuclear expression and t(11;18)(q21;q21) indicate nonresponsiveness to Helicobacter pylori eradication of Chinese primary gastric MALT lymphoma. Int J Hematol. 2008;88:516-523
21. Terai S, Iijima K, Kato K, et al. Long-term outcomes of gastric mucosa-associated lymphoid tissue lymphomas after Helicobacter pylori eradication therapy. Tohoku J Exp Med. 2008;214:79-87
22. Nakamura T, Seto M, Tajika M, et al. Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 status. Am J Gastroenterol. 2008;103:62-70
23. Sumida T, Kitadai Y, Hiyama T, et al. Antibodies to Helicobacter pylori and CagA protein are associated with the response to antibacterial therapy in patients with H. pyloripositive API2-MALT1-negative gastric MALT lymphoma. Cancer Sci. 2009;100:1075-1081
24. Park HS, Kim YJ, Yang WI, et al. Treatment outcome of localized Helicobacter pylori-negative low-grade gastric MALT lymphoma. World J Gastroenterol. 2010;16:2158-2162
25. Nakamura S, Sugiyama T, Matsumoto T, et al. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: A multicentre cohort follow-up study of 420 patients in Japan. Gut. 2012;61:507-513
26. Cavanna L, Pagani R, Seghini P, et al. High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: Report of a case and review of the literature. World J Surg Oncol. 2008;6:35
27. Morini S, Zullo A, Hassan C, et al. Gastric cardia inflammation: Role of Helicobacter pylori infection and symptoms of gastroesophageal reflux disease. Am J Gastroenterol. 2001; 96:2337-2340
28. Pietroiusti A, Forlini A, Magrini A, et al. Isolated H. pylori duodenal colonization and idiopathic duodenal ulcers. Am J Gastroenterol. 2008;103:55-61
29. Neumann WL, Lujan GM, Genta RM. Gastric heterotopia in the proximal oesophagus ("inlet patch"): Association with adenocarcinomas arising in Barrett mucosa. Dig Liver Dis. 2012;44:292-296
30. Owen RJ. Bacteriology of Helicobacter pylori. Bailliere's Clinical Gastroenterol. 1995;9:415-446
31. Mesnard B, De Vroey B, Maunoury V, et al. A new case of immunoproliferative small intestinal disease associated with Campylobacter jejuni. Dig Liver Dis. 2012;44:799-800
32. Fischbach W, Tacke W, Greiner A, et al. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. Lancet. 1997;349:31-32
33. Dutta U, Udawat H, Noor MT, et al. Regression of immunoproliferative small intestinal disease after eradication of Helicobacter pylori. J Gastrointest Cancer. 2010;41:212-215
34. Genta RM. From the Alps to Sicily: A panorama of Italian lymphomas. Dig Liver Dis. 2009;41:463-464
35. Doglioni C, Ponzoni M, Ferreri AJ, et al. Gastric lymphoma: The histology report. Dig Liver Dis. 2011;43(suppl 4): S310-S318